Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling

Redox Biology

Volumn 3, Issue , 2014, Pages 7-15

  Schattenberg, Jörn M ^a   Czaja, Mark J ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alcoholic liver disease; C Jun N terminal kinase; Cytochrome P450 2E1; Mitogen activated protein kinases; Oxidative stress

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; CANNABIDIOL; CYTOCHROME P450 2E1; HYDROGEN PEROXIDE; MENADIONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; PARACETAMOL; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ADIPOCYTE; ALCOHOL LIVER DISEASE; ARTICLE; AUTOPHAGY; CELL DEATH; DISEASE COURSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FATTY LIVER; HUMAN; INTRACELLULAR SIGNALING; LIVER CELL; LIVER INJURY; LYMPHOCYTE; MONOCYTE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; ANIMAL; DRUG EFFECTS; GENETICS; LIVER; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CYTOCHROME P-450 CYP2E1; FATTY LIVER; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MAP KINASE SIGNALING SYSTEM; MOLECULAR TARGETED THERAPY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84908690423     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.09.004     Document Type: Review

References (87)

1. Cederbaum A.I. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Digestive Diseases (Basel, Switzerland) 2010, 28:802-811. http://www.ncbi.nlm.nih.gov/pubmed/21525766, 10.1159/000324289.
2. Osawa Y., Nagaki M., Banno Y., Yamada Y., Imose M., Nozawa Y., Moriwaki H., Nakashima S. Possible involvement of reactive oxygen species in D-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. Journal of Cellular Physiology 2001, 187:374-385. http://www.ncbi.nlm.nih.gov/pubmed/11319761, 10.1002/jcp.1088.
3. Ramachandran A., Lebofsky M., Baines C.P., Lemasters J.J., Jaeschke H. Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radical Research 2011, 45:156-164. http://www.ncbi.nlm.nih.gov/pubmed/20942566, 10.3109/10715762.2010.520319.
4. Lesage G., Glaser S., Ueno Y., Alvaro D., Baiocchi L., Kanno N., Phinizy J.L., Francis H., Alpini G. Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. American Journal of Physiology. Gastrointestinal and Liver Physiology 2001, 281:G182-G190. http://www.ncbi.nlm.nih.gov/pubmed/11408271.
5. Yerushalmi B., Dahl R., Devereaux M.W., Gumpricht E., Sokol R.J. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology (Baltimore, MD) 2001, 33:616-626. http://www.ncbi.nlm.nih.gov/pubmed/11230742, 10.1053/jhep.2001.22702.
6. Zhou W., Zhang Y., Hosch M.S., Lang A., Zwacka R.M., Engelhardt J.F. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion. Hepatology (Baltimore, MD) 2001, 33:902-914. http://www.ncbi.nlm.nih.gov/pubmed/11283855, 10.1053/jhep.2001.23073.
7. Czaja M.J. Cell signaling in oxidative stress-induced liver injury. Seminars in Liver Disease 2007, 27:378-389. http://www.ncbi.nlm.nih.gov/pubmed/17979074, 10.1055/s-2007-991514.
8. Singh R., Czaja M.J. Regulation of hepatocyte apoptosis by oxidative stress. Journal of Gastroenterology and Hepatology 2007, 22(Suppl. 1):S45-S48. http://www.ncbi.nlm.nih.gov/pubmed/17567464, 10.1111/j.1440-1746.2006.04646.x.
9. Holmström K.M., Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nature Reviews. Molecular Cell Biology 2014, 15:411-421. http://www.ncbi.nlm.nih.gov/pubmed/24854789, 10.1038/nrm3801.
10. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252. http://www.ncbi.nlm.nih.gov/pubmed/11057897, 10.1016/S0092-8674(00)00116-1.
11. Czaja M.J. The future of GI and liver research: Editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death. American Journal of Physiology. Gastrointestinal and Liver Physiology 2003, 284:G875-G879. http://www.ncbi.nlm.nih.gov/pubmed/12736142, 10.1152/ajpgi.00549.2002.
12. Czaja M.J. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends in Endocrinology and Metabolism: TEM 2010, 21:707-713. http://www.ncbi.nlm.nih.gov/pubmed/20888782, 10.1016/j.tem.2010.08.010.
13. Seki E., Brenner D.A., Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 2012, 143:307-320. http://www.ncbi.nlm.nih.gov/pubmed/22705006, 10.1053/j.gastro.2012.06.004.
14. Weston C.R., Davis R.J. The JNK signal transduction pathway. Current Opinion in Genetics and Development 2002, 12:14-21. http://www.ncbi.nlm.nih.gov/pubmed/11790549, 10.1016/S0959-437X(01)00258-1.
15. Constant S.L., Dong C., Yang D.D., Wysk M., Davis R.J., Flavell R.A. JNK1 is required for T cell-mediated immunity against Leishmania major infection. Journal of Immunology (Baltimore, MD: 1950) 2000, 165:2671-2676. http://www.ncbi.nlm.nih.gov/pubmed/10946297, 10.4049/jimmunol.165.5.2671.
16. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999, 22:667-676. http://www.ncbi.nlm.nih.gov/pubmed/10230788, 10.1016/S0896-6273(00)80727-8.
17. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mechanisms of Development 1999, 89:115-124. http://www.ncbi.nlm.nih.gov/pubmed/10559486, 10.1016/S0925-4773(99)00213-0.
18. Schattenberg J.M., Wörns M.A., Zimmermann T., He Y.W., Galle P.R., Schuchmann M. The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes. Free Radical Biology and Medicine 2012, 52:1911-1917. http://www.ncbi.nlm.nih.gov/pubmed/22406316, 10.1016/j.freeradbiomed.2012.02.049.
19. Chen W., White M.A., Cobb M.H. Stimulus-specific requirements for MAP3 kinases in activating the JNK pathway. Journal of Biological Chemistry 2002, 277:49105-49110. http://www.ncbi.nlm.nih.gov/pubmed/12351623, 10.1074/jbc.M204934200.
20. Morrison D.K., Davis R.J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annual Review of Cell and Developmental Biology 2003, 19:91-118.
21. Keyse S.M. Protein phosphatases and the regulation of MAP kinase activity. Seminars in Cell and Developmental Biology 1998, 9:143-152. http://www.ncbi.nlm.nih.gov/pubmed/9599409, 10.1006/scdb.1997.0219.
22. Kamata H., Honda S., Maeda S., Chang L., Hirata H., Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661. http://www.ncbi.nlm.nih.gov/pubmed/15766528, 10.1016/j.cell.2004.12.041.
23. Venugopal S.K., Chen J., Zhang Y., Clemens D., Follenzi A., Zern M.A. Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells. Journal of Biological Chemistry 2007, 282:31900-31908. http://www.ncbi.nlm.nih.gov/pubmed/17848570, 10.1074/jbc.M703729200.
24. Bogoyevitch M.A., Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiology and Molecular Biology Reviews: MMBR 2006, 70:1061-1095. http://www.ncbi.nlm.nih.gov/pubmed/17158707, 10.1128/MMBR.00025-06.
25. Czaja M.J., Liu H., Wang Y. Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling. Hepatology (Baltimore, MD) 2003, 37:1405-1413. http://www.ncbi.nlm.nih.gov/pubmed/12774020, 10.1053/jhep.2003.50233.
26. Liu H., Lo C.R., Czaja M.J. NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology (Baltimore, MD) 2002, 35:772-778. http://www.ncbi.nlm.nih.gov/pubmed/11915022, 10.1053/jhep.2002.32534.
27. Amir M., Liu K., Zhao E., Czaja M.J. Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death. Journal of Cellular Biochemistry 2012, 113:3254-3265. http://www.ncbi.nlm.nih.gov/pubmed/22644775, 10.1002/jcb.24203.
28. Singh R., Wang Y., Xiang Y., Tanaka K.E., Gaarde W.A., Czaja M.J. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology (Baltimore, MD) 2009, 49:87-96. http://www.ncbi.nlm.nih.gov/pubmed/19053047, 10.1002/hep.22578.
29. Conde de la Rosa L., Schoemaker M.H., Vrenken T.E., Buist-Homan M., Havinga R., Jansen P.L., Moshage H. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. Journal of Hepatology 2006, 44:918-929. http://www.ncbi.nlm.nih.gov/pubmed/16310883, 10.1016/j.jhep.2005.07.034.
30. Aroor A.R., Jackson D.E., Shukla S.D. Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats. Alcoholism, Clinical and Experimental Research 2011, 35:2128-2138. http://www.ncbi.nlm.nih.gov/pubmed/21790671, 10.1111/j.1530-0277.2011.01577.x.
31. Wang Y., Schattenberg J.M., Rigoli R.M., Storz P., Czaja M.J. Hepatocyte resistance to oxidative stress is dependent on protein kinase C-mediated down-regulation of c-Jun/AP-1. Journal of Biological Chemistry 2004, 279:31089-31097. http://www.ncbi.nlm.nih.gov/pubmed/15145937, 10.1074/jbc.M404170200.
32. Conde de la Rosa L., Vrenken T.E., Hannivoort R.A., Buist-Homan M., Havinga R., Slebos D.J., Kauffman H.F., Faber K.N., Jansen P.L., Moshage H. Carbon monoxide blocks oxidative stress-induced hepatocyte apoptosis via inhibition of the p54 JNK isoform. Free Radical BiologyMedicine 2008, 44:1323-1333. http://www.ncbi.nlm.nih.gov/pubmed/18206660, 10.1016/j.freeradbiomed.2007.12.011.
33. Rosseland C.M., Wierød L., Oksvold M.P., Werner H., Ostvold A.C., Thoresen G.H., Paulsen R.E., Huitfeldt H.S., Skarpen E. Cytoplasmic retention of peroxide-activated ERK provides survival in primary cultures of rat hepatocytes. Hepatology (Baltimore, MD) 2005, 42:200-207. http://www.ncbi.nlm.nih.gov/pubmed/15962331, 10.1002/hep.20762.
34. David Josephy P. The molecular toxicology of acetaminophen. Drug Metabolism Reviews 2005, 37:581-594. http://www.ncbi.nlm.nih.gov/pubmed/16393886, 10.1080/03602530500205200.
35. Gunawan B.K., Liu Z.X., Han D., Hanawa N., Gaarde W.A., Kaplowitz N. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 2006, 131:165-178. http://www.ncbi.nlm.nih.gov/pubmed/16831600, 10.1053/j.gastro.2006.03.045.
36. Hanawa N., Shinohara M., Saberi B., Gaarde W.A., Han D., Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. Journal of Biological Chemistry 2008, 283:13565-13577. http://www.ncbi.nlm.nih.gov/pubmed/18337250, 10.1074/jbc.M708916200.
37. Win S., Than T.A., Han D., Petrovic L.M., Kaplowitz N. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. Journal of Biological Chemistry 2011, 286:35071-35078. http://www.ncbi.nlm.nih.gov/pubmed/21844199, 10.1074/jbc.M111.276089.
38. Leung T.M., Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. Journal of Hepatology 2013, 58:395-398. http://www.ncbi.nlm.nih.gov/pubmed/22940046, 10.1016/j.jhep.2012.08.018.
39. Cederbaum A.I., Lu Y., Wu D. Role of oxidative stress in alcohol-induced liver injury. Archives of Toxicology 2009, 83:519-548. http://www.ncbi.nlm.nih.gov/pubmed/19448996, 10.1007/s00204-009-0432-0.
40. Lu Y., Wu D., Wang X., Ward S.C., Cederbaum A.I. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radical Biology and Medicine 2010, 49:1406-1416. http://www.ncbi.nlm.nih.gov/pubmed/20692331, 10.1016/j.freeradbiomed.2010.07.026.
41. Wu D., Cederbaum A. Activation of ASK-1 and downstream MAP kinases in cytochrome P4502E1 potentiated tumor necrosis factor alpha liver injury. Free Radical Biology and Medicine 2010, 49:348-360. http://www.ncbi.nlm.nih.gov/pubmed/20438834, 10.1016/j.freeradbiomed.2010.04.021.
42. Cederbaum A.I., Yang L., Wang X., Wu D. CYP2E1 sensitizes the liver to LPS- and TNF α-induced toxicity via elevated oxidative and nitrosative stress and activation of ASK-1 and JNK mitogen-activated kinases. International Journal of Hepatology 2012, 2012:582790. http://www.ncbi.nlm.nih.gov/pubmed/22028977, 10.1155/2012/582790.
43. Zhuge J., Cederbaum A.I. Inhibition of the mitochondrial permeability transition by cyclosporin A prevents pyrazole plus lipopolysaccharide-induced liver injury in mice. Free Radical Biology and Medicine 2009, 46:406-413. http://www.ncbi.nlm.nih.gov/pubmed/19026739, 10.1016/j.freeradbiomed.2008.10.037.
44. Wang X., Cederbaum A.I. S-adenosyl-l-methionine decreases the elevated hepatotoxicity induced by Fas agonistic antibody plus acute ethanol pretreatment in mice. Archives of Biochemistry and Biophysics 2008, 477:1-11. http://www.ncbi.nlm.nih.gov/pubmed/18482574, 10.1016/j.abb.2008.04.033.
45. -/- mice. Hepatology (Baltimore, MD) 2011, 54:1753-1766. http://www.ncbi.nlm.nih.gov/pubmed/21748763, 10.1002/hep.24540.
46. Schattenberg J.M., Singh R., Wang Y., Lefkowitch J.H., Rigoli R.M., Scherer P.E., Czaja M.J. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology (Baltimore, MD) 2006, 43:163-172. http://www.ncbi.nlm.nih.gov/pubmed/16374858, 10.1002/hep.20999.
47. Jimenez-Lopez J.M., Wu D., Cederbaum A.I. Synergistic toxicity induced by prolonged glutathione depletion and inhibition of nuclear factor-kappaB signaling in liver cells. Toxicology in Vitro: An International Journal Published in Association with BIBRA 2008, 22:106-115. http://www.ncbi.nlm.nih.gov/pubmed/17920235, 10.1016/j.tiv.2007.08.012.
48. Yang L., Wu D., Wang X., Cederbaum A.I. Depletion of cytosolic or mitochondrial thioredoxin increases CYP2E1-induced oxidative stress via an ASK-1-JNK1 pathway in HepG2 cells. Free Radical Biology and Medicine 2011, 51:185-196. http://www.ncbi.nlm.nih.gov/pubmed/21557999, 10.1016/j.freeradbiomed.2011.04.030.
49. Czaja M.J. Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology 2011, 140:1895-1908. http://www.ncbi.nlm.nih.gov/pubmed/21530520, 10.1053/j.gastro.2011.04.038.
50. Czaja M.J. Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications. American Journal of Physiology. Cell Physiology 2010, 298:C973-C978. http://www.ncbi.nlm.nih.gov/pubmed/20089934, 10.1152/ajpcell.00527.2009.
51. Ding W.X., Li M., Chen X., Ni H.M., Lin C.W., Gao W., Lu B., Stolz D.B., Clemens D.L., Yin X.M. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology 2010, 139:1740-1752. http://www.ncbi.nlm.nih.gov/pubmed/20659474, 10.1053/j.gastro.2010.07.041.
52. Dolganiuc A., Thomes P.G., Ding W.X., Lemasters J.J., Donohue T.M. Autophagy in alcohol-induced liver diseases. Alcoholism, Clinical and Experimental Research 2012, 36:1301-1308. http://www.ncbi.nlm.nih.gov/pubmed/22551004, 10.1111/j.1530-0277.2012.01742.x.
53. Wang Y., Singh R., Xiang Y., Czaja M.J. Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress. Hepatology (Baltimore, MD) 2010, 52:266-277. http://www.ncbi.nlm.nih.gov/pubmed/20578144, 10.1002/hep.23645.
54. Lin C.W., Zhang H., Li M., Xiong X., Chen X., Chen X., Dong X.C., Yin X.M. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. Journal of Hepatology 2013, 58:993-999. http://www.ncbi.nlm.nih.gov/pubmed/23339953, 10.1016/j.jhep.2013.01.011.
55. Yang L., Wu D., Wang X., Cederbaum A.I. Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver. Free Radical BiologyMedicine 2012, 53:1170-1180. http://www.ncbi.nlm.nih.gov/pubmed/22749809, 10.1016/j.freeradbiomed.2012.06.029.
56. Wei Y., Pattingre S., Sinha S., Bassik M., Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Molecular Cell 2008, 30:678-688. http://www.ncbi.nlm.nih.gov/pubmed/18570871, 10.1016/j.molcel.2008.06.001.
57. Wu D., Cederbaum A.I. Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK. Redox Biology 2013, 1:552-565. http://www.ncbi.nlm.nih.gov/pubmed/24273738, 10.1016/j.redox.2013.10.008.
58. Yang L., Rozenfeld R., Wu D., Devi L.A., Zhang Z., Cederbaum A. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radical Biology andMedicine 2014, 68:260-267. http://www.ncbi.nlm.nih.gov/pubmed/24398069, 10.1016/j.freeradbiomed.2013.12.026.
59. Wu D., Wang X., Zhou R., Yang L., Cederbaum A.I. Alcohol steatosis and cytotoxicity: The role of cytochrome P4502E1 and autophagy. Free Radical Biology and Medicine 2012, 53:1346-1357. http://www.ncbi.nlm.nih.gov/pubmed/22819980, 10.1016/j.freeradbiomed.2012.07.005.
60. Tang H., Sebastian B.M., Axhemi A., Chen X., Hillian A.D., Jacobsen D.W., Nagy L.E. Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes. Alcoholism, Clinical and Experimental Research 2012, 36:214-222. http://www.ncbi.nlm.nih.gov/pubmed/21895711, 10.1111/j.1530-0277.2011.01607.x.
61. Sebastian B.M., Roychowdhury S., Tang H., Hillian A.D., Feldstein A.E., Stahl G.L., Takahashi K., Nagy L.E. Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice. Journal of Biological Chemistry 2011, 286:35989-35997. http://www.ncbi.nlm.nih.gov/pubmed/21856753, 10.1074/jbc.M111.254201.
62. Sharma A., Saurabh K., Yadav S., Jain S.K., Parmar D. Ethanol induced induction of cytochrome P450 2E1 and activation of mitogen activated protein kinases in peripheral blood lymphocytes. Xenobiotica; The Fate of Foreign Compounds in Biological Systems 2012, 42:317-326. http://www.ncbi.nlm.nih.gov/pubmed/21999510, 10.3109/00498254.2011.624648.
63. Jin M., Ande A., Kumar A., Kumar S. Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway. Cell Death and Disease 2013, 4:e554. http://www.ncbi.nlm.nih.gov/pubmed/23519123, 10.1038/cddis.2013.78.
64. Jones B.E., Liu H., Lo C.R., Koop D.R., Czaja M.J. Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress. Antioxidants a Redox Signaling 2002, 4:701-709. http://www.ncbi.nlm.nih.gov/pubmed/12470497, 10.1089/152308602760598846.
65. Schattenberg J.M., Wang Y., Rigoli R.M., Koop D.R., Czaja M.J. CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling. Hepatology (Baltimore, MD) 2004, 39:444-455. http://www.ncbi.nlm.nih.gov/pubmed/14767997, 10.1002/hep.20067.
66. Singh R., Wang Y., Schattenberg J.M., Xiang Y., Czaja M.J. Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation. American Journal of Physiology. Gastrointestinal and Liver Physiology 2009, 297:G907-G917. http://www.ncbi.nlm.nih.gov/pubmed/20501438, 10.1152/ajpgi.00151.2009.
67. Liu H., Jones B.E., Bradham C., Czaja M.J. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha. American Journal of Physiology. Gastrointestinal and Liver Physiology 2002, 282:G257-G266. http://www.ncbi.nlm.nih.gov/pubmed/11804847, 10.1152/ajpgi.00304.2001.
68. Wang X., Lu Y., Xie B., Cederbaum A.I. Chronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: Role of CYP2E1 and TNF-alpha and activation of JNK and P38 MAP kinase. Free Radical Biology and Medicine 2009, 47:518-528. http://www.ncbi.nlm.nih.gov/pubmed/19477265, 10.1016/j.freeradbiomed.2009.05.021.
69. Ristow M. Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits. Nature Medicine 2014, 20:709-711. http://www.ncbi.nlm.nih.gov/pubmed/24999941, 10.1038/nm.3624.
70. Kawagishi H., Finkel T. Unraveling the truth about antioxidants: ROS and disease: finding the right balance. Nature Medicine 2014, 20:711-713. http://www.ncbi.nlm.nih.gov/pubmed/24999942, 10.1038/nm.3625.
71. Stickel F., Seitz H.K. Update on the management of alcoholic steatohepatitis. Journal of Gastrointestinal and Liver Diseases: JGLD 2013, 22:189-197. http://www.ncbi.nlm.nih.gov/pubmed/23799218.
72. Tariq Z., Green C.J., Hodson L. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (Nash)?. Liver International: Official Journal of the International Association for the Study of the Liver 2014, 34:e180-e190. http://www.ncbi.nlm.nih.gov/pubmed/24621397, 10.1111/liv.12523.
73. Neuschwander-Tetri B.A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology (Baltimore, MD) 2010, 52:774-788. http://www.ncbi.nlm.nih.gov/pubmed/20683968, 10.1002/hep.23719.
74. Abdelmegeed M.A., Banerjee A., Yoo S.H., Jang S., Gonzalez F.J., Song B.J. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. Journal of Hepatology 2012, 57:860-866. http://www.ncbi.nlm.nih.gov/pubmed/22668639, 10.1016/j.jhep.2012.05.019.
75. Weltman M.D., Farrell G.C., Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996, 111:1645-1653. http://www.ncbi.nlm.nih.gov/pubmed/8942745, 10.1016/S0016-5085(96)70028-8.
76. Chalasani N., Gorski J.C., Asghar M.S., Asghar A., Foresman B., Hall S.D., Crabb D.W. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 2003, 37:544-550. http://www.ncbi.nlm.nih.gov/pubmed/12601351, 10.1053/jhep.2003.50095.
77. Weltman M.D., Farrell G.C., Hall P., Ingelman-Sundberg M., Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 1998, 27:128-133. http://www.ncbi.nlm.nih.gov/pubmed/9425928, 10.1002/hep.510270121.
78. Schattenberg J.M., Wang Y., Singh R., Rigoli R.M., Czaja M.J. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. Journal of Biological Chemistry 2005, 280:9887-9894. http://www.ncbi.nlm.nih.gov/pubmed/15632182, 10.1074/jbc.M410310200.
79. Kathirvel E., Morgan K., French S.W., Morgan T.R. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. European Journal of Gastroenterology and Hepatology 2009, 21:973-983. http://www.ncbi.nlm.nih.gov/pubmed/19307976, 10.1097/MEG.0b013e328328f461.
80. Woodcroft K.J., Hafner M.S., Novak R.F. Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology (Baltimore, MD) 2002, 35:263-273. http://www.ncbi.nlm.nih.gov/pubmed/11826398, 10.1053/jhep.2002.30691.
81. Abdelmegeed M.A., Carruthers N.J., Woodcroft K.J., Kim S.K., Novak R.F. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. Journal of Pharmacology and Experimental Therapeutics 2005, 315:203-213. http://www.ncbi.nlm.nih.gov/pubmed/15980059, 10.1124/jpet.105.084608.
82. Musso G., Cassader M., Olivetti C., Rosina F., Carbone G., Gambino R. Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 2013, 14:417-431. http://www.ncbi.nlm.nih.gov/pubmed/23387384, 10.1111/obr.12020.
83. Piguet A.C., Stroka D., Zimmermann A., Dufour J.F. Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clinical Science (London, England: 1979) 2010, 118:401-410. http://www.ncbi.nlm.nih.gov/pubmed/19832698, 10.1042/CS20090313.
84. Sanyal A.J., Chalasani N., Kowdley K.V., McCullough A., Diehl A.M., Bass N.M., Neuschwander-Tetri B.A., Lavine J.E., Tonascia J., Unalp A., Van Natta M., Clark J., Brunt E.M., Kleiner D.E., Hoofnagle J.H., Robuck P.R. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. New England Journal of Medicine 2010, 362:1675-1685. http://www.ncbi.nlm.nih.gov/pubmed/20427778, 10.1056/NEJMoa0907929.
85. Guy C.D., Suzuki A., Abdelmalek M.F., Burchette J.L., Diehl A.M. Treatment response in the PIVENS Trial is associated with decreased hedgehog pathway activity. Hepatology (Baltimore, MD) 2014, http://www.ncbi.nlm.nih.gov/pubmed/24849310, 10.1002/hep.27235.
86. Athinarayanan S., Wei R., Zhang M., Bai S., Traber M.G., Yates K., Cummings O.W., Molleston J., Liu W., Chalasani N. Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials. PloS One 2014, 9:e95366. http://www.ncbi.nlm.nih.gov/pubmed/24759732, 10.1371/journal.pone.0095366.
87. McDonough K.H. Antioxidant nutrients and alcohol. Toxicology 2003, 189:89-97. http://www.ncbi.nlm.nih.gov/pubmed/12821285, 10.1016/S0300-483X(03)00155-0.